Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Coughlin Christopher J, Director. Officer active across 6 companies, notably CENTENE CORP. Aggregated, 33 filings have been recorded. Split: 2 buys · 1 sell. Total volume traded: €1.6m. History available since 20 May 2021. The latest transaction was filed on 12 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Coughlin Christopher J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2,495 shares0Common Stock, par value $0.01 per shareSEC:0001104659-22-085713:0
25 of 33 declarations
About Coughlin Christopher J
COUGHLIN CHRISTOPHER J is Director at CENTENE CORP, Karuna Therapeutics, Inc., Prestige Consumer Healthcare Inc. and ALEXION PHARMACEUTICALS, INC. He has 33 filings in total, and across the 33 sampled filings from 2021-05-24 to 2026-07-01, buys amount to EUR 1495125 and sells to EUR 362512, with the modal transaction nature listed as Attribution.